The highest mortality rate due to breast cancer in the US is seen in black women and the lowest in Asian American Pacific ...

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...

Airway Therapeutics is to launch a Phase III trial of zelpultide alfa, a drug to prevent bronchopulmonary dysplasia in ...

MSD will provide KEYTRUDA for the Exelixis-sponsored Phase III STELLAR-305 trial. Credit: JeanLucIchard/Shutterstock. US-based biotechnology companies Exelixis and ...

Data from the Rainbowfish trial was presented at the World Muscle Society (WMS) Congress 2024 in Prague, Czech Republic.

Repare Therapeutics has dosed the first subject in its Phase I POLAR trial of RP-3467 as a potential treatment for various solid tumours.

CEPI is preparing to initiate Phase II trials for a human vaccine candidate against Rift Valley fever in Kenya.

Mater Research have commenced a trial for a combined Covid-19 and flu vaccine of Novavax for individuals who cannot receive ...

Capricor has licenced out the US, European and Japanese marketing rights to the therapy to Nippon. Image credit: Pavel Kapysh / Shutterstock. Capricor Therapeutics has released more positive ...

Underactive bladder affects 28% men over 50 with lower urinary tract symptoms and 45% of older women. Image credit: Shutterstock/Aria sandi hasim. Astellas Pharma subsidiary, iota Biosciences, has won ...

As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).